Charles Rhyee's Stock Ratings

TD Cowen Analyst

Charles Rhyee is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025

Overall Average Return

-13.1%

Smart Score

37.9%

Overall Average Return Percentile

18th

Number of Ratings

98
Buy NowGet Alert
01/08/2025CAHBuy Now
Cardinal Health
$131.409.59%
Charles Rhyee37%
$130 → $144UpgradeHold → BuyGet Alert
11/11/2024CRLBuy Now
Charles River
$176.9428.29%
Charles Rhyee37%
$203 → $227MaintainsHoldGet Alert
11/11/2024FTREBuy Now
Fortrea Holdings
$9.64159.34%
Charles Rhyee37%
$23 → $25MaintainsHoldGet Alert
10/31/2024TDOCBuy Now
Teladoc Health
$8.42-4.99%
Charles Rhyee37%
$9 → $8MaintainsHoldGet Alert
10/25/2024ICLRBuy Now
Icon
$186.0353.2%
Charles Rhyee37%
$369 → $285MaintainsBuyGet Alert
10/23/2024MEDPBuy Now
Medpace Hldgs
$322.9315.2%
Charles Rhyee37%
$413 → $372MaintainsBuyGet Alert
08/29/2024VEEVBuy Now
Veeva Systems
$236.43-18.79%
Charles Rhyee37%
$180 → $192MaintainsHoldGet Alert
08/13/2024FTREBuy Now
Fortrea Holdings
$9.64138.59%
Charles Rhyee37%
$27 → $23MaintainsHoldGet Alert
08/12/2024CRLBuy Now
Charles River
$176.9414.73%
Charles Rhyee37%
$228 → $203MaintainsHoldGet Alert
08/05/2024RCMBuy Now
R1 RCM
Charles Rhyee37%
$20 → $14.3DowngradeBuy → HoldGet Alert
08/01/2024TDOCBuy Now
Teladoc Health
$8.426.89%
Charles Rhyee37%
$15 → $9MaintainsHoldGet Alert
07/24/2024MEDPBuy Now
Medpace Hldgs
$322.9334.39%
Charles Rhyee37%
$452 → $434MaintainsBuyGet Alert
05/31/2024ICLRBuy Now
Icon
$186.03100.51%
Charles Rhyee37%
$349 → $373MaintainsBuyGet Alert
05/29/2024MEDPBuy Now
Medpace Hldgs
$322.9339.97%
Charles Rhyee37%
→ $452Initiates → BuyGet Alert
05/29/2024FTREBuy Now
Fortrea Holdings
$9.64180.08%
Charles Rhyee37%
→ $27Initiates → HoldGet Alert
05/28/2024MDRXBuy Now
Veradigm
$5.15191.26%
Charles Rhyee37%
$26 → $15MaintainsBuyGet Alert
05/16/2024GDRXBuy Now
GoodRx Holdings
$4.61247.07%
Charles Rhyee37%
$14 → $16MaintainsBuyGet Alert
05/13/2024CRLBuy Now
Charles River
$176.9428.86%
Charles Rhyee37%
$260 → $228MaintainsHoldGet Alert
04/26/2024TDOCBuy Now
Teladoc Health
$8.4278.15%
Charles Rhyee37%
$16 → $15MaintainsHoldGet Alert
04/26/2024ICLRBuy Now
Icon
$186.0387.6%
Charles Rhyee37%
$343 → $349MaintainsBuyGet Alert
03/01/2024GDRXBuy Now
GoodRx Holdings
$4.61203.69%
Charles Rhyee37%
$12 → $14MaintainsOutperformGet Alert
09/25/2023CRLBuy Now
Charles River
$176.9418.12%
Charles Rhyee37%
$212 → $209MaintainsMarket PerformGet Alert
09/13/2023CRLBuy Now
Charles River
$176.9419.81%
Charles Rhyee37%
→ $212Initiates → Market PerformGet Alert
08/16/2023CAHBuy Now
Cardinal Health
$131.40-31.51%
Charles Rhyee37%
$88 → $90MaintainsMarket PerformGet Alert
08/07/2023ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$205 → $215MaintainsOutperformGet Alert
07/31/2023GDRXBuy Now
GoodRx Holdings
$4.61160.3%
Charles Rhyee37%
$6.5 → $12UpgradeMarket Perform → OutperformGet Alert
05/03/2023TALKBuy Now
Talkspace
$2.7383.16%
Charles Rhyee37%
$4 → $5MaintainsOutperformGet Alert
05/03/2023ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$174 → $187MaintainsOutperformGet Alert
03/23/2023AMWLBuy Now
American Well
$7.95-68.55%
Charles Rhyee37%
$100 → $50DowngradeOutperform → Market PerformGet Alert
03/20/2023PEARBuy Now
Pear Therapeutics
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
03/06/2023VEEVBuy Now
Veeva Sys
$236.43-20.06%
Charles Rhyee37%
$184 → $189MaintainsMarket PerformGet Alert
02/10/2023ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$173 → $174MaintainsOutperformGet Alert
12/06/2022VEEVBuy Now
Veeva Sys
$236.43-22.18%
Charles Rhyee37%
→ $184Initiates → Market PerformGet Alert
12/06/2022IQVBuy Now
IQVIA Hldgs
$188.5433.13%
Charles Rhyee37%
→ $251Initiates → OutperformGet Alert
11/14/2022HLTHBuy Now
Cue Health
Charles Rhyee37%
$9 → $7MaintainsOutperformGet Alert
11/14/2022SNCEBuy Now
Science 37 Hldgs
Charles Rhyee37%
$140 → $60MaintainsOutperformGet Alert
11/03/2022ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$169 → $173MaintainsOutperformGet Alert
10/20/2022OWLTBuy Now
Owlet
$4.35-8.05%
Charles Rhyee37%
$70 → $56MaintainsOutperformGet Alert
08/16/2022DRIOBuy Now
DarioHealth
$0.681973.77%
Charles Rhyee37%
$18 → $14MaintainsOutperformGet Alert
08/02/2022TDOCBuy Now
Teladoc Health
$8.42303.8%
Charles Rhyee37%
$58 → $34DowngradeOutperform → Market PerformGet Alert
06/21/2022EVHBuy Now
Evolent Health
$10.11394.56%
Charles Rhyee37%
$48 → $50MaintainsOutperformGet Alert
06/13/2022GDRXBuy Now
GoodRx Holdings
$4.6195.23%
Charles Rhyee37%
$22 → $9MaintainsMarket PerformGet Alert
06/09/2022ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$171 → $170MaintainsOutperformGet Alert
05/23/2022ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$165 → $171MaintainsOutperformGet Alert
05/16/2022DRIOBuy Now
DarioHealth
$0.682566.27%
Charles Rhyee37%
$14 → $18MaintainsOutperformGet Alert
04/18/2022MCKBuy Now
McKesson
$665.89-45.79%
Charles Rhyee37%
$325 → $361MaintainsOutperformGet Alert
03/01/2022GDRXBuy Now
GoodRx Holdings
$4.61377.22%
Charles Rhyee37%
$49 → $22DowngradeOutperform → Market PerformGet Alert
02/03/2022ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$161 → $165MaintainsOutperformGet Alert
12/16/2021PEARBuy Now
Pear Therapeutics
Charles Rhyee37%
Initiates → OutperformGet Alert
11/10/2021BTTXBuy Now
Better Therapeutics
$0.00
Charles Rhyee37%
Initiates → OutperformGet Alert
11/08/2021ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$157 → $161MaintainsOutperformGet Alert
10/22/2021SNCEBuy Now
Science 37 Hldgs
Charles Rhyee37%
→ $280Initiates → OutperformGet Alert
10/19/2021HLTHBuy Now
Cue Health
Charles Rhyee37%
→ $14Initiates → OutperformGet Alert
08/24/2021AMWLBuy Now
American Well
$7.95214.47%
Charles Rhyee37%
$580 → $500MaintainsOutperformGet Alert
08/24/2021GDRXBuy Now
GoodRx Holdings
$4.61811.06%
Charles Rhyee37%
$44 → $42MaintainsOutperformGet Alert
08/09/2021ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$154 → $157MaintainsOutperformGet Alert
07/26/2021OWLTBuy Now
Owlet
$4.35221.84%
Charles Rhyee37%
→ $196Initiates → OutperformGet Alert
07/06/2021TALKBuy Now
Talkspace
$2.73376.21%
Charles Rhyee37%
→ $13Initiates → OutperformGet Alert
06/08/2021ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$150 → $154MaintainsOutperformGet Alert
04/22/2021DRIOBuy Now
DarioHealth
$0.684491.91%
Charles Rhyee37%
→ $31Initiates → OutperformGet Alert
11/09/2020ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$117 → $129MaintainsOutperformGet Alert
10/19/2020GDRXBuy Now
GoodRx Holdings
$4.611266.59%
Charles Rhyee37%
→ $63Initiates → OutperformGet Alert
10/12/2020AMWLBuy Now
American Well
$7.95415.72%
Charles Rhyee37%
→ $820Initiates → OutperformGet Alert
08/11/2020ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
$103 → $117MaintainsOutperformGet Alert
07/16/2020OTRKBuy Now
Ontrak
$1.492316.11%
Charles Rhyee37%
→ $3240Initiates → OutperformGet Alert
04/15/2020TDOCBuy Now
Teladoc Health
$8.421978.38%
Charles Rhyee37%
$150 → $175MaintainsOutperformGet Alert
03/30/2020CERNBuy Now
Cerner
Charles Rhyee37%
→ $79UpgradeMarket Perform → OutperformGet Alert
01/13/2020TDOCBuy Now
Teladoc Health
$8.421087.65%
Charles Rhyee37%
$86 → $100MaintainsOutperformGet Alert
02/13/2018PINCBuy Now
Premier
$18.5488.78%
Charles Rhyee37%
→ $35Initiates → Market PerformGet Alert
10/10/2017MCKBuy Now
McKesson
$665.89
Charles Rhyee37%
UpgradeMarket Perform → OutperformGet Alert
10/10/2017ABCBuy Now
AmerisourceBergen
Charles Rhyee37%
UpgradeMarket Perform → OutperformGet Alert
09/11/2017MDRXBuy Now
Veradigm
$5.15210.68%
Charles Rhyee37%
$13 → $16UpgradeMarket Perform → OutperformGet Alert
07/31/2017ATHNBuy Now
athenahealth
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
03/15/2017WBMDBuy Now
WebMD Health
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
01/30/2017CSLTBuy Now
Castlight Health
Charles Rhyee37%
→ $4Initiates → Market PerformGet Alert
09/16/2016RPTPBuy Now
Raptor Pharmaceutical
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
09/08/2016CERNBuy Now
Cerner
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
09/08/2016MDRXBuy Now
Veradigm
$5.15
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
09/07/2016CPHDBuy Now
Cepheid
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
07/15/2016TSLBuy Now
Trina Solar
$8.82
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
07/01/2016FTVWBuy Now
Fortive
Charles Rhyee37%
→ $46Initiates → Market PerformGet Alert
06/17/2016SWHCBuy Now
Smith & Wesson Holding
Charles Rhyee37%
$29 → $28UpgradeMarket Perform → OutperformGet Alert
06/15/2016LDRHBuy Now
LDR Holding
$24.8149.13%
Charles Rhyee37%
$33 → $37DowngradeOutperform → Market PerformGet Alert
05/26/2016BLOXBuy Now
Infoblox
Charles Rhyee37%
$32 → $28MaintainsOutperformGet Alert
05/18/2016XCOMBuy Now
Xtera Communications
Charles Rhyee37%
$7 → $4MaintainsOutperformGet Alert
05/05/2016ARIABuy Now
ARIAD Pharmaceuticals
Charles Rhyee37%
UpgradeMarket Perform → OutperformGet Alert
04/19/2016PLKIBuy Now
Popeyes Louisiana Kitchen
Charles Rhyee37%
→ $59Initiates → Market PerformGet Alert
04/14/2016POTBuy Now
Potash of Saskatchewan
Charles Rhyee37%
DowngradeMarket Perform → UnderperformGet Alert
04/07/2016BINDBuy Now
Bind Therapeutics
Charles Rhyee37%
DowngradeOutperform → Market PerformGet Alert
04/04/2016SWHCBuy Now
Smith & Wesson Holding
Charles Rhyee37%
→ $29DowngradeOutperform → Market PerformGet Alert
03/16/2016MOREBuy Now
Monogram Residential
Charles Rhyee37%
→ $13Initiates → OutperformGet Alert
03/15/2016MCKBuy Now
McKesson
$665.89-74.02%
Charles Rhyee37%
$208 → $173DowngradeOutperform → Market PerformGet Alert
01/20/2016EVHBuy Now
Evolent Health
$10.11
Charles Rhyee37%
Initiates → OutperformGet Alert
11/21/2014CERNBuy Now
Cerner
Charles Rhyee37%
$59 → $75UpgradeMarket Perform → OutperformGet Alert
02/13/2014ATHNBuy Now
athenahealth, Inc.
Charles Rhyee37%
$123 → $186UpgradeUnderperform → Market PerformGet Alert
08/13/2013ATHNBuy Now
athenahealth, Inc.
Charles Rhyee37%
$96 → $93DowngradeMarket Perform → UnderperformGet Alert
10/01/2012MDRXBuy Now
Veradigm
$5.15
Charles Rhyee37%
UpgradeNeutral → OutperformGet Alert
07/30/2012CERNBuy Now
Cerner
Charles Rhyee37%
DowngradeOutperform → NeutralGet Alert